tiprankstipranks
Trending News
More News >
Immuneering Corp. Class A (IMRX)
NASDAQ:IMRX
US Market

Compare Immuneering (IMRX) vs. Competitors

Compare
616 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Immuneering
$4.85
$308.64M
-2.99
153.08%
4 Buy
0 Hold
0 Sell
Strong Buy
Larimar Therapeutics
$3.45
$273.89M
-1.79
-0.29%
4 Buy
0 Hold
0 Sell
Strong Buy
Rocket Pharmaceuticals
$3.78
$393.93M
-1.68
-63.93%
6 Buy
3 Hold
1 Sell
Moderate Buy
Invivyd
$2.21
$620.76M
-4.67
444.33%
3 Buy
1 Hold
0 Sell
Strong Buy
Aura Biosciences Inc
$5.48
$315.61M
-2.98
-27.62%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IMRX
Immuneering
5.34
3.28
159.22%
LRMR
Larimar Therapeutics
3.45
-0.13
-3.63%
RCKT
Rocket Pharmaceuticals
3.78
-6.93
-64.71%
IMAB
IVVD
Invivyd
2.21
1.74
370.21%
AURA
Aura Biosciences Inc
5.74
-2.15
-27.25%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts